To test this idea, we experimentally manipulated proportion of the PDGF-AA and the R␣17 truncated receptor coprecipitated in this experiment ( Figure 1A , lane PDGF-A expression in the developing eye. We inhibited PDGF activity in vivo using a soluble extracellular frag-2), demonstrating that the R␣17 polypeptide is capable of binding to PDGF-AA homodimers in solution, with an ment of PDGFR␣ that can neutralize the activity of all isoforms of PDGF and also with a neutralizing antiaffinity high enough to withstand the physiological salt washes performed during the immunoprecipitation pro-PDGFR␣ monoclonal antibody. In both cases, development of the astrocyte network was retarded, strongly tocol.
To assess the ability of the R␣17 truncated receptor suggesting that PDGF mediates a developmental interaction between RGCs and astrocytes. In addition, we to inhibit the mitogenic effect of PDGF, NIH 3T3 cells were cultured in the presence of PDGF-AA, PDGF-BB, overexpressed PDGF-A in retinal neurons in transgenic mice. These transgenic animals displayed a striking hy-PDGF-AB, or basic fibroblast growth factor (bFGF) together with different concentrations of conditioned meperplasia of retinal astrocytes with their associated blood vessels, which, in older animals, bore a close dium from COS cells expressing R␣17. DNA synthetic activity was measured by 3 H-thymidine incorporation. resemblance to human proliferative retinopathy. These results emphasize the obligatory relationships among DNA synthesis induced by all three dimeric isoforms of PDGF was inhibited, in a dose-dependent manner, by neurons, astrocytes, and vasculature in the retina, and suggest that PDGF is an important component of the COS cell medium containing R␣17 but not by control cell medium ( Figure 1B ). The mitogenic activity of bFGF signaling network that coordinates growth of these cells during development.
was unaffected by R␣17. These results are consistent with the known ligand-binding properties of intact PDGFR␣, which can bind and be activated by all three Results dimeric isoforms of PDGF Gronwald et al., 1988; Hart et al., 1988) . The inhibitory effect of Sequestering PDGF in the Developing Eye R␣17 on 3 H-thymidine incorporation could in turn be with the Extracellular Domain of PDGFR␣ overcome by increasing the concentration of PDGF in Inhibits Formation of the Retinal the medium (data not shown), demonstrating that the Astrocyte Network PDGF-neutralizing effect of R␣17 is saturable. Under We wanted to test whether inhibiting PDGF signaling the conditions of our experiments, R␣17-conditioned can inhibit normal development of the retinal astrocyte medium neutralized between 1 and 3 ng/ml PDGF-AA. network. We therefore engineered a soluble extracellular A similar truncated PDGFR␣ was previously shown to fragment of PDGFR␣ as a neutralizing agent for all diinhibit ligand-induced receptor phosphorylation (Yu et meric isoforms of PDGF (see Experimental Procedures) al., 1994). and inserted it into a replicating COS cell vector. A Myc COS cells, transfected with pR␣17 and injected unilatepitope tag, recognized by monoclonal antibody 9E10 erally into the eyes of newborn rats, persisted and con- (Evan et al., 1985) , was inserted in-frame with the truntinued to express the Myc-tagged R␣17 truncated recated PDGFR␣ at its extreme carboxy terminus. The ceptor for several days in vivo (Figures 2B and 2C) . final construct was named pR␣17, and the encoded Typically, they formed a compact bolus of cells that polypeptide R␣17. The construct was electroporated remained attached to the posterior surface of the lens. into COS cells, which were fixed 72 hr later and labeled
The size of the bolus indicated that the COS cells had with monoclonal antibody 9E10. A proportion of the cells continued to proliferate in the eye following injection. was labeled, giving intense intracellular labeling of the On postnatal day 5 (P5), injected and contralateral uninsecretory apparatus (endoplasmic reticulum, Golgi apjected eyes were dissected and their retinae processed paratus, and cytoplasmic vesicles) (Pollock and Richfor whole-mount histochemistry with a monoclonal antiardson, 1992; see Figure 2A ). COS cells transfected with body against glial fibrillary acidic protein (GFAP, a spepR␣17 were metabolically labeled with 35 S-amino acids cific marker for astrocytes). Eyes that showed signs of and the cell lysate and supernatant were immunopreciphaving been damaged by the injection procedure (e.g., itated with monoclonal antibody 9E10, followed by polyblood in the vitreous) were rejected, as were eyes that acrylamide gel electrophoresis and autoradiography.
did not appear to have a COS cell tumor and eyes in The immunoprecipitates from both cell supernatant (Fig- which the COS cells had invaded the retina (approxiure 1A, lane 1) and cell lysate (data not shown) contained mately half of the injected eyes were analyzed). There high molecular weight polypeptides that were absent were no significant differences in the radii of retinae from from control immunoprecipitations (lane 4). To test the eyes injected with mock-transfected COS cells versus PDGF-binding ability of the secreted R␣17 polypeptide, uninjected eyes (data not shown), implying that the COS pR␣17 and a similar plasmid encoding the short splicecells did not inhibit overall growth of the eye. In order variant of human PDGF-A (Pollock and Richardson, to quantify the effect on astrocyte migration, the retinal 1992) were electroporated separately into cultured COS whole-mounts were divided in six sectors and the discells, which were subsequently incubated with 35 Stance of the most peripheral astrocyte to the optic nerve amino acids. The cell culture media were collected and head was measured in each sector. The average of these coincubated overnight at 4ЊC to allow PDGF-AA to bind six values was taken as a measure of the overall extent of to the truncated R␣17 receptor. The supernatants were the astrocyte network. For each experimental situation then immunoprecipitated with an antiserum raised (pR␣17-transfected COS cells, mock-transfected COS cells, contralateral eyes with no COS cell injections), nine against pure human PDGF (R and D Systems). A large (B) Neutralization of PDGF isoforms with R␣17 truncated receptor. Subconfluent cultures of NIH 3T3 cells were growth-arrested by serum deprivation. Purified growth factors were added to a fixed concentration, sufficient to stimulate half-maximal mitogenic response, together with different dilutions of conditioned medium from COS cells that had been transfected with plasmid pR␣17 (left panel, "R␣17") or with the vector backbone alone (right panel, "mock"). After overnight incubation at 37ЊC, 3 H-thymidine was added to the cultures for 4 hr before solubilizing the cells and determining the amount of TCA-precipitable radioactivity by scintillation counting. Assays were performed in triplicate. The results are expressed as a percentage of the incorporation obtained in response to growth factor alone. Conditioned medium containing R␣17 truncated receptor was able to neutralize all three dimeric isoforms of PDGF, but not bFGF, in a dose-dependent fashion. For further details, see Experimental Procedures. retinae were examined. Careful observation revealed a before birth, prior to the COS cell injections. When the extent of the astrocyte network in normal newborn rats slight rotational asymmetry in the normal distribution of astrocytes in uninjected eyes at P5. In retinae from eyes was subtracted, we found that the distance migrated by astrocytes during the course of the experiment was that had been injected with mock-transfected COS cells, the GFAP immunoreactivity reflected the normal distrireduced by 51% Ϯ 18.3% (n ϭ 9) as a result of exposure to R␣17. bution of astrocytes ( Figure 2D ). The radius of the astrocyte network (estimated as described above) was only slightly reduced, by 5% Ϯ 3.9% (mean Ϯ SD, n ϭ 9), in mock-transfected COS cell-injected eyes when Systemically Delivered Anti-PDGFR␣ Immunoglobulin Perturbs compared with contralateral uninjected eyes.
In retinae from eyes that had received COS cells exDevelopment of the Retinal Astrocyte Network pressing R␣17, development of the astrocyte network was clearly perturbed ( Figure 2E ). The effect was not As another means of inhibiting PDGF signaling, we used a rat monoclonal anti-mouse PDGFR␣ (antibody APA5) uniform across the retina, being greater in one half of the retina than the other. In those retinal sectors that that competes with PDGF-AA and PDGF-BB for binding to PDGFR␣ on Balb/c-3T3 cells (Takakura et al., 1996) were most affected, the morphology of the network was altered (compare Figures 2D and 2E) , having a less intriand inhibits PDGF-AA-induced responses in Balb/c-3T3 cells and cultured fetal liver cells (N. T., unpublished cate branching pattern compared with control retinae. In addition, the extent of the retinal astrocyte network data). Newborn mice were injected subcutaneously with 50 g of column-purified APA5 Ig once each day for 3 was dramatically reduced in the more affected half of the retina. To quantify this effect, we compared the radial days, then they were processed for whole-mount immunohistochemistry with anti-GFAP and anti-collagen IV. distances covered by astrocytes in the two most affected sectors of each retina that was exposed to
Littermates that had been injected with 50 g of monoclonal rat anti-mouse c-Kit Ig (antibody ACK2) or with pR␣17-transfected COS cells with the two shortest distances measured in each retina that was exposed to vehicle alone served as controls. To test whether the subcutaneously injected antibodies reached the eye and mock-transfected COS cells; we found a reduction in the R␣17-treated retinae of 31% Ϯ 9.6% (n ϭ 9, p < bound to retinal astrocytes, we performed whole-mount immunohistochemistry with FITC-conjugated goat-anti-0.01 Student's t-test). However, part of these measured distances had already been traveled by the astrocytes rat IgG (Figures 3A-3C ). In mice injected with APA5, the anti-rat IgG-FITC conjugate clearly outlined the astroIgG immunoreactivity in ACK2-injected mice on an unidentified subset of retinal cells located near the optic cyte network ( Figure 3A) , whereas in mice treated with ACK2 or PBS, no staining above background was obnerve head at P5 (data not shown), demonstrating that ACK2 had reached the retina. served ( Figures 3B and 3C ). Mice treated with ACK2 showed reduced skin pigmentation as described pre-
The retinal astrocyte network (revealed by GFAP immunolabeling) in P3 mice injected with APA5 was strikviously (Nishikawa et al., 1991) , indicating that the control antibody was active. We were able to localize rat ingly perturbed in morphology and reduced in radial than normal ( Figure 3 ). As in the R␣17 experiment described above, the effect was more pronounced in one half of the retina than in the other. It is likely that inherent asymmetrical properties of the developing retina are the root cause of the uneven effect of systemic APA5 injection (and, by extrapolation, R␣17 treatment too). In addition to the disturbed morphology of the astrocyte network found in APA5-injected mice, there was also a reduction in the extent of astrocyte migration. Combining data from three independent experiments, the average radial distance migrated over all six sectors of the APA5-treated retinae (n ϭ 13) was reduced by 20% Ϯ 1.2% compared with ACK2-treated retinae (n ϭ 10).
There is believed to be a close link between the development of retinal astrocytes and blood vessels (see below), so we also examined the retinal vasculature in APA5-injected eyes. There was possibly a small inhibitory effect on the vasculature, but this was much less pronounced than the effect on astrocytes and we did not attempt quantitation. Vascular cells do not express PDGFR␣ so a direct effect of the antibody on these cells is not expected.
Transgenic Mice That Overexpress PDGF-A in Neurons
We generated transgenic mice that express PDGF-A in subsets of central and peripheral neurons under transcriptional control of the rat neuron-specific enolase (NSE) gene promoter (Forss-Petter et al., 1990) . The transgene contained a human PDGF-A cDNA engineered to encode the "short" alternative-splice isoform of PDGF-A with a Myc epitope tag appended to the carboxy terminus (hPDGF-A; Figure 4A ) (Pollock and Richardson, 1992) . The "short" PDGF-A isoform is freely diffusible in the extracellular fluid, since it lacks the extracellular matrix-binding motif present at the carboxy Ö stman et al., 1991; Khachigian et al., 1992;  neck each day from birth to P3 with rat-anti-mouse PDGFR␣ Ig (A), Pollock and Richardson, 1992; Raines and Ross, 1992) . transcriptase (RT)-PCR approach to examine expression of transgene-derived hPDGF-A mRNA in the retinae of each line (e.g., Figure 4B ). The PCR primers were spread when compared with control retinae from ACK2-chosen to amplify PDGF-A transcripts across the Myc injected mice ( Figures 3D and 3E ). The ACK2 injections epitope sequences near the 3Ј end of the transgene. had no effect on the retinal astrocyte network when Thus, transgene-derived human PDGF-A transcripts compared with retinae from mice injected with vehicle could be distinguished unambiguously from endogealone. In APA5-injected mice, the astrocytes seemed to nous mouse transcripts by the size of the PCR product be more fasciculated and possibly reduced in numbers, after Southern blotting and probing with a PDGF-A-specific oligonucleotide. Reprobing the Southern blot with because the astrocyte network had a more open mesh showing the predicted structures of the transgenic (hPDGF-A) and endogenous (mPDGF-A) mRNAs, and the relative positions of oligonucleotide PCR primers (arrows) and hybridization probes (P1, P2) used for detection. The position of exon 6 (69 bp), which encodes an extracellular matrix binding motif that can be inserted by alternative splicing, is indicated. Right, agarose gel electrophoresis of RT-PCR products generated from line A5-75 transgenic (tg) or wild-type (wt) P3 retinae and a control reaction (ϪRT) in which reverse transcriptase was omitted from the PCR reaction, Southern blotted, and probed with 32 Plabeled probes P1 (detects all PDGF-A mRNA species) or P2 (detects only transgenederived mRNA). The predicted sizes of the PCR products are 211 bp ("short" mPDGF-A mRNA lacking exon 6), 280 bp ("long" mPDGF-A mRNA including exon 6), or 318 bp (transgenic hPDGF-A mRNA). A series of control experiments established that our RT-PCR reaction conditions were such that the band intensities after blotting were proportional to the amount of mRNA added; band intensities could therefore be compared on a semiquantitative basis. Densitometry of gel lanes indicated that there were about five times as many transgene-derived PDGF-A transcripts as endogenous transcripts in the neural retina of line A5-75, and also that no "long" form mPDGF-A mRNA can be detected in wild-type or transgenic retinae. (C) Immunofluorescence localization of transgene-derived hPDGF-A in the retina of a P14 transgenic mouse expressing the ER-retained form of hPDGF-A (see [A] ). Monoclonal 9E10 (anti-c-Myc) was the primary antibody; FITC-conjugated rabbit-anti-mouse IgG was the secondary antibody. The transgenic retina is on the right, a wild-type littermate on the left. The strongest signal is detected in the cell bodies of retinal ganglion cells (RGC); a weaker signal is detected in the cell bodies of photoreceptor cells in the outer nuclear layer (ONL, arrowheads), and in the inner nuclear layer (INL, arrows). The strong signal in the pigment epithelium (PE) is background autofluorescence. Retinal astrocytes migrate into the retina along the plane of the nerve fibre layer (NFL), which contains the projection axons of RGCs. IPL, inner plexiform layer; OPL, outer plexiform layer; IS, OS inner and outer segments of the photoreceptor cells. Scale bar, 50 m.
a specific c-myc oligonucleotide provided further proof
We were unable to detect any immunoreactivity over background in retinae from any of the NSE-PDGF-A mice of the transgenic derivation of the transcripts ( Figure  4B ). Three of the four NSE-PDGF-A transgenic mouse using antibody 9E10, which recognizes the Myc epitope present in the transgene-encoded hPDGF-A. However, lines and two of the four NSE-PDGF-AKDEL lines expressed transgene-derived mRNA (data not shown). We in both of the NSE-PDGF-AKDEL lines, we could easily visualize the encoded polypeptide in the cell bodies of quantified the mRNA expression level in hemizygous mice of line A5-75 by densitometry of Southern blots in RGCs and, at a lower level, in neurons in the inner and outer nuclear layers ( Figure 4C ). The protein was abuna BioRad Molecular Imager (see Experimental Procedures). At birth, P3, and P14, there were between five dant in all RGCs from before the day of birth (data not shown) to at least the end of the second postnatal week and seven times more transgene-derived hPDGF-A transcripts than endogenous transcripts in the neural retinae ( Figure 4C ) and was still expressed, at a lower level, in the adult (data not shown). The spatial expression of these mice. Expression of both transgenic and endogeneous PDGF-A declined somewhat in the adult, alpattern, in particular expression in RGCs, was similar to that previously described for an NSE-lacZ transgene though transgenic PDGF-A was still more abundant. (Forss-Petter et al., 1990; Seiler and Aramant, 1995) and littermates of one of the lines, called A5-75. At P4, the homozygous animals displayed a retinal astrocyte phean NSE-BCL2 transgene (Martinou et al., 1994) , demonstrating that the activity of the NSE promoter cassette notype that was clearly more severe than that of the hemizygotes ( Figures 5B and 5C ). The homozygotes is not markedly affected in cis by flanking chromosomal sequences at the site of integration. Thus, it seems very (which have a double complement of transgenes and, presumably, correspondingly higher PDGF-A expreslikely that the expression pattern of the PDGF-A KDEL transgene is a faithful representation of the expression sion) had a much denser mat of GFAP ϩ astrocyte processes than either the hemizygotes or wild-types (Figpattern of the secreted PDGF-A transgene. We conclude, therefore, that our NSE-PDGF-A transgenic mice ures 5A-5C). The radial spread of astrocytes from the optic nerve head was less in the homozygotes than in synthesize the encoded PDGF polypeptide in RGCs and other retinal neurons but that this does not accumulate the hemizygotes at P4, and less in the hemizygotes than in wild-type mice ( Figures 5A-5C ). At P4, for example, to a detectable degree either inside cells or in the extracellular space following secretion. This conclusion is the average radius of the astrocyte net was reduced by 41% Ϯ 10.6% (n ϭ 10) in heterozygotes and by 59% Ϯ strongly supported by phenotypic analysis of the NSE-PDGF-A mice (see below). Note that the expression pat-1.3% (n ϭ 5) in homozygotes compared with wild type. Possible reasons for this effect are discussed later. tern of transgene-derived PDGF-A is not dissimilar to the endogenous pattern of PDGF-A expression (Mudhar However, despite the fact that astrocyte migration was retarded in A5-75 mice during early postnatal developet al., 1993) . Both are expressed in the great majority of RGCs, with no noticeable gradient of expression from ment, the astrocytes did eventually reach all the way to the periphery of the transgenic retinae. central-to-peripheral at postnatal ages. Endogenous PDGF-A is also expressed in a subset of amacrine neurons in the inner nuclear layer, whereas transgenic Hypervascularization of the Retina in NSE-PDGF-A Transgenic Mice PDGF-A is expressed in neurons in both the inner and outer nuclear layers.
It is known that astrocytes influence retinal vasculogenesis during normal development (see Discussion), so we The RT-PCR assay was also able to distinguish between endogenous mouse mRNAs that encoded predicted that the increased number of astrocytes in NSE-PDGF-A transgenic retinae might in turn induce the "short" and "long" alternative splice isoforms of PDGF-A. Only the "short" isoform was detected in wildoverproduction of blood vessels. We used antibodies against GFAP and collagen IV to specifically label type or transgenic mice, demonstrating that only this isoform is normally produced in the P3 mouse retina.
astrocytes and blood vessels (Herken et al., 1990; Connolly, 1991) , respectively. We compared the gliovascular nets in retinae of P4 wild-type, hemizygous, and homoHyperplasia of the Retinal Astrocyte Network zygous transgenic (A5-75) animals ( Figures 5D-5F ).
in NSE-PDGF-A Mice
There was a striking correspondence between the During normal development, retinal astrocytes migrate astrocyte and vascular nets in all three genotypes; not radially across the inner surface (i.e., the nerve fiber only was there transgene dose-dependent overproduclayer) of the retina from the optic nerve head, starting tion of blood vessels in the transgenic retinae, but the around the day of birth and reaching the periphery of distribution of vessels closely matched the distribution the retina around postnatal day 5 (P5) in the rat and the of astrocyte processes; that is, the vessels did not mouse (Watanabe and Raff, 1988; Mudhar et al., 1993;  spread further than the astrocytes. The correspondence M. F., unpublished data). Since retinal astrocytes exbetween astrocytes and blood vessels is particularly press PDGFR␣ (Mudhar et al., 1993), which can be actiobvious in Figures 5C and 5F , which depict the same vated by all three dimeric isoforms of PDGF (AA, AB, homozygous retina labeled with both antibodies. Thus, BB), we expected that development of retinal astrocytes not only is there a higher density of vessels in retinae that might be perturbed in the NSE-PDGF-A mice. Immunocontain more astrocytes, but the distribution of vessels histochemistry with antibodies against GFAP revealed seems to be restricted by the extent of the astrocyte that all three transgenic lines that expressed transgenenetwork. This emphasizes the interdependence of derived mRNA displayed hyperplasia of the retinal astrocytes and blood vessels during both normal and astrocyte network ( Figure 5 ). The fourth NSE-PDGF-A abnormal retinal development. line (A5-72) that did not express the transgene had no During early postnatal development, the NSE-PDGF-A phenotype (data not shown), demonstrating a correlaretinae displayed retinal hemorrhage, especially in hotion between transgene expression (at the mRNA level) mozygous animals (data not shown). This might be a and phenotype. It is noteworthy that neither of the two result of overproduction of vascular endothelial cell NSE-PDGF-AKDEL transgenic lines had any retinal phenogrowth factor/vascular permeability factor (VEGF/VPF) type, despite the fact that the ER-retained PDGF-A acby the excess astrocytes in these retinae. Retinal cumulated to a high level in RGCs of these mice ( Figure  astrocytes have been shown to express VEGF/VPF in an 4C). This provides strong genetic evidence that the pheoxygen-dependent manner during normal development notype of the NSE-PDGF-A mice depends on the ability (Shweiki et al., 1992; Stone et al., 1995) . of the transgene-derived PDGF protein to be secreted from the cells that synthesize it.
Retinal Astrocytes in NSE-PDGF-A Mice Are More We investigated the transgene dose dependence of Numerous and Proliferate More than Normal the retinal astrocyte phenotype of NSE-PDGF-A mice
To confirm that the abnormal appearance of the astrocyte net in NSE-PDGF-A mice was due to increased by comparing hemizygous and homozygous transgenic A] ). In the hemizygous transgenic animal (E), the retinal vessels form a denser network; there appear to be more and thicker vessels compared with wild-type. Note that the transgenic vascular net extends approximately to the leading edge of the astrocyte net, but does not overtake it (compare with [B] ). In the homozygous transgenic retina (F), the vasculature forms a dense mat and extends a relatively short distance from the optic nerve head, closely corresponding to the distribution of astrocytes (compare with [C] , which shows the same retina double-labeled for GFAP). Thus, the distribution of blood vessels in the transgenic retinae appears to be determined by the distribution of astrocytes. In (F), note vessels growing away from the retina into the vitreous (arrows). Scale bar, 200 m.
numbers of astrocytes rather than, for example, more astrocytes in the transgenic retinae. For example, it is possible that increased survival of astrocytes also conextensive GFAP ϩ processes on the same number of cells, we enzymatically dissociated individual retinae tributes to the phenotype. from P3 and P6 wild-type and transgenic (A5-75) retinae and labeled them in suspension with anti-GFAP antibodAdult NSE-PDGF-A Mice Display a Phenotype Resembling Human Proliferative Retinopathy ies followed by FITC-conjugated second antibodies. The cells were also incubated with propidium iodide (PI) to
In normal adult retinae, astrocytes are only found on the inner surface and never deep within the retina (Figure label nuclear DNA and analyzed in a fluorescence-activated cell scanner (FACS). Representative primary FACS 7A). In adult transgenics, the astrocytes formed an abnormally tight mesh on the inner surface of the retina data for one wild-type and one hemizygous transgenic mouse are shown in Figures 6A and 6B , and combined (data not shown) and, in addition, penetrated into the neural retina to form abnormal extensions of the net data from several animals are plotted in Figures 6D and  6E (details in the figure legend) . A control in which the throughout the retina and even as deep as the retinal pigmented epithelium ( Figure 7B ). primary antibody (anti-GFAP) was omitted is shown in Figure 6C . Cells with GFAP labeling greater than backIn adult wild-type mice, blood vessels are limited to well defined planes at the inner surface of the retina and ground (boxed regions in the FACS plots of Figures  6A-6C ) were counted as a proportion of the total retinal in the plexiform layers (arrows in Figure 7C ), where they border the inner nuclear layer (Engerman and Meyer, cell population. There were more than twice the normal number of GFAP ϩ astrocytes in the transgenic retinae 1965; Connolly, 1991). The outer vascular network develops during the second postnatal week by budding from at P3, and about four times the normal number at P6 ( Figure 6D ). In the transgenic retinae, there was also a the inner vasculature, and is independent of astrocytes (Engerman and Meyer, 1965; Stone et al., 1995) . In adult higher proportion of astrocytes in the S, G2, and M phases of the cell cycle (15.6% Ϯ 2.4% compared with hemizygous transgenics, blood vessels penetrated into all layers of the retina right out to the photoreceptor 10.4% Ϯ 1.0% in wild type, means Ϯ SDs). This suggests that proliferation of astrocytes is enhanced in the layer (arrows in Figure 7D ). Confocal microscopy revealed that they were colocalized with GFAP ϩ glial cells, transgenic retinae. We cannot yet say whether this effect accounts completely for the increased number of most likely astrocytes (data not shown). The lamellar suggests that PDGF-A might mediate a short-range paracrine interaction between these two cell types during normal development (Mudhar et al., 1993) . The experiments reported here were designed to test whether such an interaction does occur and, if so, what the nature of the interaction might be. We attempted to inhibit PDGF signaling through PDGFR␣ on astrocytes, both with a blocking anti-PDGFR␣ antibody and also with a soluble extracellular fragment of PDGFR␣. Both treatments resulted in significant but incomplete inhibition of astrocyte migration and a reduced branching pattern of the astrocyte network. Because we cannot tell to what extent PDGF signaling was inhibited in our experiments, we cannot deduce whether PDGF is wholly or only partly responsible for astrocyte proliferation/migration during development. It is possible that development of the astrocyte network depends solely on PDGF and that our inhibitory regimes were inadequate to reveal this. It is perhaps more likely that PDGF normally acts in concert with other factors whose individual contributions to astrocyte development are relatively small but whose combined effects are cumulative. If so, eliminating any one of them would not necessarily have a catastrophic effect.
To gain further information about the activity of PDGF-A in the retina, we generated transgenic mice that express PDGF-A under control of the NSE promoter. Although we were unable to visualize the transgenederived secreted PDGF-A directly in situ, we showed, in two independent lines of transgenic mice, that an ERretained form of PDGF-A under NSE control is expressed tion is that the time the cells spend in G1 is reduced in proportion to the time spent in S/G2 and M, that is, the cell cycle is accelerated. Alternatively, the proportion of structure of the retina was disrupted in places, presumastrocytes that is actively engaged in the cell cycle might ably a physical effect of the invading vasculature (large be increased in the transgenic mice. At present, we arrow, Figure 7D ).
cannot distinguish between these possibilities. Nevertheless, we can conclude from the present data that Discussion PDGF-A overproduction in the transgenic mice has a positive effect on retinal astrocyte proliferation. It is posThe fact that PDGF-A and PDGFR␣ are expressed in sible that there is also an effect on astrocyte survival. The fact that increased levels of PDGF-A stimulate the rodent retina by RGCs and astrocytes, respectively, astrocyte proliferation demonstrates that neither PDGF-A abolished at higher concentrations (12 ng/ml), whereas the proliferative response to PDGF-AA is monophasic nor any other mitogenic factor is available in the normal developing mouse retina at a concentration that is satuand reaches a plateau at comparatively high concentrations (25 ng/ml) (Abedi et al., 1995) . PDGF-AA has also rating for astrocyte proliferation. It follows that the number of astrocytes that develop in the retina could potenbeen reported to antagonize PDGF-BB-stimulated cell migration (Siegbahn et al., 1990; Koyama et al., 1992) . tially be determined by the rate of supply of PDGF-A, which in turn depends on the number of RGCs. It is It seems likely that the signal transduction pathways that stimulate cell proliferation and migration interact known that the final number of RGCs, in common with many other neuronal populations, depends on survival but, in general, the relationship between proliferation and migration is poorly understood. An alternative exsignals from their target cells. It is also strongly suspected that the number of vascular cells that develop planation for the altered distribution of astrocytes in the transgenic retinae might be that this reflects an altered in the retina depends on astrocytes (see below), and the data presented here support this idea. Therefore, expression pattern of PDGF-A. We think that this is less likely, because the postnatal expression pattern of our there appears to be a hierarchy of sequential cell-cell interactions among vascular cells, astrocytes, RGCs and ER-retained form of PDGF-A and other NSE-driven transgenes (Forss-Petter et al., 1990; Martinou et al. , their target cells, the purpose of which is to ensure that each cell population develops in proportion to the 1994; Seiler and Aramant, 1995) is rather similar to the expression pattern of endogeneous PDGF-A (Mudhar others. We suggest that PDGF-AA is an important link in this chain of number-matching interactions, acting et al., 1993). Both transgene-derived and endogenous PDGF-A are expressed in the great majority of RGCs all as an RGC-derived mitogen for astrocytes and thereby controlling the proportion of astrocytes to RGCs. the way from optic nerve head to the retinal periphery, and in other retinal neurons in the inner and outer nuclear An unexpected finding was that, despite the considerable increase in astrocyte numbers in the transgenics, layers. A striking aspect of the transgenic phenotype was the migration away from the optic nerve head was retarded. Superficially, it might appear that stimulating and inhibclose correspondence between the distribution patterns of retinal astrocytes and blood vessels. In wild-type iting PDGF signaling have similar effects on the astrocyte network but this is not so; inhibiting PDGF signaling mice, the astrocytes migrate from the optic nerve head slightly ahead of the developing vascular network. In with the R␣17 truncated receptor or APA5 anti-PDGFR␣ Ig resulted in a less extensive and more sparse astrocyte transgenic retinae, where astrocyte migration was retarded, the leading edge of the blood vessels caught network, whereas increasing PDGF supply in the transgenics resulted in a less extensive but much denser up with but did not overtake the astrocyte front. This was true even in homozygous transgenic retinae, where network. PDGF-AA has been reported to either stimulate or inhibit cell migration, depending on its concentration astrocyte migration was severely inhibited. This is consistent with the view that physical proximity of astroand the cell type under investigation (Ferns et al., 1990; Siegbahn et al., 1990; Uren et al., 1994; cytes is required for retinal vasculogenesis. Retinal astrocytes express PDGFR␣ and probably respond di1994a; Iguchi et al., 1995) . For example, migration of Swiss 3T3 fibroblasts in vitro is maximal at relatively rectly to the transgene-encoded hPDGF-A. However, vascular cells express PDGFR␤ (Mudhar et al., 1993) low PDGF-AA concentrations (3 ng/ml) and completely and would not be expected to respond directly to PDGF-1991) . Therefore, our transgenic mice might model a naturally occurring human disease state and could AA Coats et al., 1994) . In keeping with this expectation, neither pericytes nor endothelial prove useful for testing potential treatments for some aspects of the proliferative retinopathies. cells respond to PDGF-AA in vitro (D'Amore and Smith, 1993) . Therefore, vascular cells in the transgenic retinae are probably stimulated by secondary signals from the
Experimental Procedures
PDGF-AA-responsive astrocytes. A strong candidate for
Construction of pR␣17 Plasmid Expression Vector
an astrocyte-derived vasculogenic factor is VEGF/VPF A full-length cDNA encoding rat PDGFR␣ (Lee et al., 1990 ) was (Barinaga, 1995) . This factor is synthesized by retinal obtained from R. Reed (John Hopkins, Baltimore). A 1.7 kb fragment astrocytes in vivo , and is regulated of this cDNA was obtained following digestion with EcoRI and NotI, by oxygen tension both in vivo and in vitro. Thus, experiand inserted into a COS cell expression vector based on pHYK mentally induced hypoxia results in up-regulation of (Pollock and Richardson, 1992) , which contains the adenovirus major late promoter, polyadenylation site from the herpesvirus type-1 VEGF mRNA and stimulates vasculogenesis (Shweiki et Pierce et al., 1995; Stavri et vector can replicate autonomously in COS cells under the influence al., 1995; Stone et al., 1995) , whereas hyperoxia has the of the endogenous SV40 large-T antigen. The PDGFR␣ insert inreverse effect . We did not investigate cludes a small amount of 5Ј noncoding sequence, followed by the VEGF expression in our transgenic mice, but the fact initiation codon and coding sequence up to, but not including, the that the overextended retinal vasculature was leaky and transmembrane domain. The mode of construction also placed a c-Myc epitope tag in-frame at the extreme carboxy terminus of released blood into the retina is consistent with the the encoded receptor fragment, so that it could be recognized by known activities of VEGF/VPF (Connolly, 1991) . monoclonal antibody 9E10 (Evan et al., 1985) . The final construct
In adult NSE-PDGF-A transgenic retinae, astrocytes was named pR␣17, and the encoded polypeptide R␣17.
were distributed throughout the depth of the retina, including the inner and outer plexiform layers and as far
Electroporation of COS Cells
out as the retinal pigment epithelium. This is in striking DNA-encoding truncated rat PDGFR␣ (R␣17) or a similar plasmid contrast to wild-type retinae, in which astrocytes are encoding the short splice-variant of human PDGF-A (Pollock and found only at the inner retinal surface . Richardson, 1992) blindness (D'Amore, 1994; Barinaga, 1995) . VEGF is now thought to play a key role in ischemia-associated reti-
Immunoprecipitation and Gel Electrophoresis
nopathies such as PDR and retinopathy of prematurity 35 S-labeled supernatants from COS cells expressing truncated rat (Aiello et al., 1994; D'Amore, 1994;  PDGFR␣, or human PDGF-A, were preincubated with 10 Ϫ3 volume of normal mouse serum for 1 hr at 4ЊC, then with protein A-Sepha- Barinaga, 1995; . Retinal astrocytes rose for 1 hr, followed by centrifugation at 15,000 ϫ g for 10 min.
are known to produce VEGF (see above) and are thought The R␣17 supernatant was then incubated with an equal volume of to participate in the pathogenesis of human retinopaeither DMEM or PDGF-A supernatant for 16 hr at 4ЊC. The supernathies (Jerdan et al., 1986; Sramek et al., 1989 ; Ohira and tants were immunoprecipitated with either mouse monoclonal anti- de Juan, 1990; Hosada et al., 1993; . body 9E10 or rabbit antiserum raised against PDGF from human Thus, factors that influence astrocytes (such as PDGFplatelets (R and D Systems, Minneapolis). After precipitation of immune complexes with protein A-Sepharose, they were electropho-AA) might be expected to deregulate VEGF production, resed on a 10% nonreducing polyacrylamide gel containing SDS resulting in neovascularization. PDGF and PDGF recepand visualized by fluorography (Bonner and Laskey, 1974 (Takakura et al., 1996) . Hybridoma culture-supernatants were precipitated with saturated amonium sulfate at 50% (v/v) fied by metal ion chromatography from human platelets ; a generous gift from Carl-Henrik Heldin), with concentration. The precipitate was further purified by anionexchange chromatography (Clezardin et al., 1985) . A monoclonal or without medium conditioned by COS cells expressing R␣17, was added to the cells, which were cultured for a further 16 hr at 37ЊC rat antibody (IgG 2a) against mouse c-Kit (clone ACK2; Nishikawa et al., 1991) was used as a negative control for the effects of APA5. before the addition of 1-3 Ci of 3 H-thymidine. The concentrations of growth factors used were sufficient to exert a half-maximal effect Fluorescein isothiocyanate (FITC)-conjugated anti-mouse antibodies, FITC-conjugated anti-rat antibodies, FITC-conjugated anti-rabon 3 H-thymidine incorporation in the absence of any conditioned medium: 2 ng/ml for PDGF-AA and PDGF-AB, and 0.5 ng/ml for bit antibodies, and tetramethyl rhodamine isothiocyanate (TRITC)-conjugated anti-rabbit antibodies (Sigma Immuno Chemicals) were PDGF-BB and bFGF. After 4 hr incubation in the presence of 3 H-thymidine, the medium was removed and the cells lysed and used as secondary antibodies. washed in situ three times with ice-cold 5% (w/v) trichloracetic acid (TCA). The precipitates remaining attached to the plastic were Production of Transgenic Mice solubilized in 0.5 M NaOH, 1% (w/v) sodium dodecyl sulfate (SDS).
Mice that overexpress PDGF-A in neurons under control of the NSE The incorporated radioactivity was estimated by scintillation countgene promoter were generated at the UMDS Transgenic Unit, The ing in Aquasol (Dupont).
Rayne Institute, St. Thomas's Hospital, London SEI 7EH. The transgene consisted of a partial human PDGF-A cDNA (Betsholtz et al., 1986) engineered to encode the "short" alternative splice PDGF-A Intravitreal Injection of COS Cells isoform (Tong et al., 1987; Bonthron et al., 1988 ; Rorsman et al., For injection into the eyes of newborn rats, COS cells were cultured 1988) with a Myc epitope tag (Evan et al., 1985) at its carboxy for 48 hr after electroporation, trypsinized and washed, and resusterminus, fused to the rat NSE promoter (Forss-Petter et al., 1990 ) pended in HEPES MEM at a concentration of ‫2ف‬ ϫ 10 6 cells/ml. In and the SV40 early polyadenylation site ( Figure 4A ). In brief, the SacII parallel, COS cells on coverslips from the same electroporation site upstream of the initiation codon in plasmid "PDGF-A SϩTAG" experiment were subjected to immunofluorescence microscopy (Pollock and Richardson, 1992 ) was converted to a HindIII site by T4 with antibody 9E10 to monitor expression levels. COS cells were bacteriophage DNA polymerase treatment and addition of a HindIII not used for intravitreal injection unless the proportion expressing linker, then a HindIII-EcoRI fragment containing the complete hu-R␣17 was greater than 15%. Approximately 10 3 cells (0.5 l) were man PDGF-A coding sequence with Myc tag attached and part of injected into the posterior chamber of one eye of newborn rat pups.
the PDGF-A mRNA 3Ј untranslated region was excised and used to The neonates were anesthetized with Metofane (C-Vet Ltd., Bury St.
replace the lacZ fusion gene in plasmid "NSElacZ" (Forss-Petter et Edmunds), and the eyelids eased apart using a pair of microscissors al., 1990), leaving the SV40 poly(A)-addition site intact. This placed under a dissecting microscope. Using a Hamilton syringe with a 34 human PDGF-A under the control of 1.8 kb of rat NSE promoter gauge needle, the cells were injected over a period of 2 min. After sequences and the SV40 early poladenylation site. The entire NSEcompletion of the injection, the needle was left in position for 30 s PDGF-SV40 cassette was purified as a linear EcoRI fragment for to reduce reflux of the injected cells. Control injections of mockinjection into mouse oocytes (C57Bl/6 ϫ CBA f1 hybrids). electroporated COS cells, or the vehicle alone, were always conducted on rats from the same litter.
Identification and Genotyping of Transgenic Animals
Tail clippings were digested overnight at 55ЊC in a buffer containing Histology and Immunocytochemistry 50 mM Tris (pH 8), 10 mM EDTA, 100 mM sodium chloride, 1% For whole-mount preparations, eyes were removed and given a brief (w/v) SDS, and 50 mg/ml proteinase K (Sigma). Following RNase A fixation in 4% (w/v) paraformaldehyde in phosphate-buffered saline treatment (100 g/ml, 1 hr at 37ЊC), ammonium acetate was added (PBS). The retinae were subsequently dissected and fixed in iceto a final concentration of 2 M, chilled on ice, and centrifuged to cold methanol. After incubating in PBS containing 50% fetal calf precipitate proteins. DNA in the supernatant was precipitated with serum (FCS) and 1% (w/v) Triton X-100 for 30 min at room tempera-0.6 vol of cold isopropanol and washed with 70% ethanol. The DNA ture, the retinae were incubated overnight at room temperature in pellet was dissolved in water overnight at 4ЊC. Yields were estimated primary antibody, washed for 1 hr in PBS, incubated for 3 hr at room from absorbance at 260 nm, and DNA aliquots (10 g) were digested temperature in fluorescent secondary antibody, washed for 1 hr, with restriction enzymes and subjected to Southern blot analysis. and mounted in Citifluor anti-fade reagent (City University, London).
The blots were hybridized with a PDGF-A chain cDNA probe radiolaAll antibodies were diluted in PBS containing 10% FCS. For cryosecbeled by random priming (Feinberg and Vogelstein, 1984) . tions, eyes were removed and fixed in 4% (w/v) paraformaldehyde in PBS for 1 hr and cryoprotected in 30% (w/v) solution of sucrose RT-PCR in PBS. Retinae were dissected in PBS, embedded in OCT (Raymond Retinae were dissected from wild-type and transgenic littermates A. Lamp, London), and frozen in isopentane cooled by liquid nitroand homogenized in guanidinium isothiocyanate, and total cellular gen. Cryosections (12 m nominal thickness) were prepared and RNA was prepared as described previously (Chomczynski and Sacstained as previously described (Mudhar et al., 1993) . For semithin chi, 1987) . This was treated with 400 units/ml RNase-free DNase 1 sections, deeply anaesthetized animals were perfused with cacodyl-(Pharmacia) for 15 min at 37ЊC, then phenol/chloroform-extracted ate buffer (0.1 M [pH 7.4]) containing 4% (w/v) paraformaldehyde and precipitated with ethanol. Total RNA (2 g) was reverse-tranand 2% (w/v) glutaraldehyde. Retinae were dissected, fixed in cacoscribed into cDNA using the Superscript preamplification system dylate buffer containing 2% (w/v) OsO 4, dehydrated in ethanol, and (Gibco-BRL). PDGF-A sequences were then specifically amplified embedded in TAAB resin (TAAB Laboratories Equipment Ltd., Enby PCR (25 cycles of the following): 94ЊC, 30 s; 55ЊC, 2 min; 72ЊC, gland). Semithin sections (1 m nominal thickness) were stained 2 min; concluding with 72ЊC, 10 min). The PCR primers were as with methylene blue, 0.2% (w/v) in water.
follows: 5Ј-GTCCAGGTGAGGTTAGAGGA-3Ј (upstream) and 5Ј-TCA CGGAGGAGAACAAAGAC-3Ј (downstream). These hybridized to both endogenous (mouse) and transgenic (human) PDGF-A seAntibodies For whole-mount preparations, a mouse monoclonal antibody quences without mismatch. RNA titration experiments showed that the RT-PCR reaction was semiquantitative under these condiraised against pig glial fibrillary acidic protein (GFAP) (Sigma Immuno Chemicals) and a polyclonal rabbit antibody raised against tions (i.e., operating in the linear range). The PCR products were separated on a 2% (w/v) agarose gel, which was Southern blotted murine collagen IV (Biogenesis, England) were used as primary antibodies. A polyclonal rabbit anti-GFAP antibody (Pruss, 1979) was onto nylon membrane (Zetaprobe, BioRad) and probed with 32 Plabeled (using polynucleotide kinase) oligonucleotide probes used in flow cytometry. The latter anti-GFAP antibody and monoclonal antibody 9E10 (Evan et al., 1985) were used for immunohistoagainst either PDGF-A or the Myc epitope tag (see Figure 4) . The oligonucleotide probe against PDGF-A was an equimolar mixture chemistry on cryosections. The monoclonal antibody (IgG 2a) against PDGFR␣ (clone APA5) was raised against recombinant of two 39-mers, 5Ј-AAGCACCATACATAGTATGTTCAGGAATGTCA CACGCCA-3Ј (mouse) and 5Ј-AAGCACCGTACATAGTAGGTTCAGG mouse PDGFR␣ in rat and competes with PDGF for binding to
